Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rangering i aksjer #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aksjekurs
$72.44
Sist synkronisert: 2026-08-24
Markedsverdi
$20.13B
Endring (1 dag)
1.25%
Endring (1 år)
17.60%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Aksjeprishistorikk for Novonesis (Novozymes) B (NSISBC)
Høyeste sluttskurs: $67.87 den 2026-08-01

Laveste sluttskurs: $58.74 den 2024-03-01
Aksjeprishistorikk for Novonesis (Novozymes) B fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -0.15%
2025 7.42%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$487.92 2.11%
GB
$198.92 4.22%
FR
$346.89 -5.48%
US
$287.25 3.19%
US
$306.31 4.13%
US